List of insiders holdings for Aprea Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | HealthCap VII L.P. HealthCap VII GP S.A. 10% Owner | 2022-11-15 17:08:05 | 2,366,104 0 | 2,366,104 | Form 13D |
| 2 | KDev Investments AB Karolinska Development AB KCIF Co-Investment Fund KB 10% Owner | 2021-02-16 06:51:58 | 1,780,691 0 | 1,780,691 | Form 13G |
| 3 | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder | 2021-02-16 17:08:15 | 619,157 0 | 619,157 | Form 13D |
| 4 | Gilad Oren President/CEO | 2026-03-16 18:07:28 | 474,595 1,800 | 476,395 | Form 4 |
| 5 | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 2020-05-20 21:58:59 | 333,333 6,968 | 340,301 | Form 4 |
| 6 | SCHADE CHRISTIAN S Director | 2022-08-01 17:06:17 | 306,846 11,000 | 317,846 | Form 4 |
| 7 | Duey Marc Director | 2025-12-11 08:31:55 | 277,614 602 | 278,216 | Form 4 |
| 8 | Peters Richard Director | 2026-04-01 16:15:17 | 247,830 0 | 247,830 | Form 4 |
| 9 | Coiante Scott M SVP, Chief Financial Officer | 2022-08-01 17:00:42 | 234,265 0 | 234,265 | Form 4 |
| 10 | Abrahmsen Lars B. SVP, Chief Scientific Officer | 2022-03-14 17:01:04 | 143,700 0 | 143,700 | Form 4 |
| 11 | Wessels Gregory S. SVP, Chief Commercial Officer | 2021-03-01 19:10:17 | 82,000 0 | 82,000 | Form 4 |
| 12 | Korbel Gregory Alan SVP, Chief Operating Officer | 2022-08-01 17:04:13 | 81,462 0 | 81,462 | Form 4 |
| 13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2026-04-01 16:15:55 | 61,956 0 | 61,956 | Form 4 |
| 14 | Attar Eyal C. SVP, Chief Medical Officer | 2022-06-07 17:00:32 | 57,233 331 | 57,564 | Form 4 |
| 15 | Seizinger Bernd R. Director | 2025-06-09 16:07:40 | 49,960 0 | 49,960 | Form 4 |
| 16 | Mirza Nadeem Q. Chief Medical Officer | 2024-05-02 16:16:29 | 33,650 0 | 33,650 | Form 4 |
| 17 | Kelly Michael Aaron Director | 2021-07-01 19:07:34 | 27,360 0 | 27,360 | Form 4 |
| 18 | Namouni Fouad Director | 2021-07-01 18:58:01 | 27,360 0 | 27,360 | Form 4 |
| 19 | Pamukcu Rifat Director | 2025-06-09 16:06:08 | 9,631 14,108 | 23,739 | Form 4 |
| 20 | HENNEMAN JOHN B III Director | 2025-06-09 16:05:29 | 14,414 0 | 14,414 | Form 4 |
| 21 | Grissinger Michael Director | 2025-06-09 16:03:35 | 7,074 0 | 7,074 | Form 4 |
| 22 | Magni Guido Director | 2019-10-07 19:25:54 | 6,500 0 | 6,500 | Form 4 |
| 23 | Hepple Jonathan Director | 2020-07-01 18:03:19 | 5,600 0 | 5,600 | Form 4 |
| 24 | Christenson Johan Director | 2020-07-01 18:01:06 | 5,600 0 | 5,600 | Form 4 |
| 25 | BIZZARI JEAN-PIERRE Director | 2025-06-09 16:01:14 | 5,230 0 | 5,230 | Form 4 |
| 26 | Gruia Gabriela Director | 2025-06-09 16:04:28 | 5,230 0 | 5,230 | Form 4 |
| 27 | Redmile Group LLC Green Jeremy 10% Owner | 2022-02-14 17:07:14 | 0 0 | 0 | Form 13G |
| 28 | Versant V Luxco S.a r.l. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner | 2022-02-10 20:44:54 | 0 0 | 0 | Form 13G |
| 29 | Versant V Luxco S.a r.l. Versant Ventures V LLC Versant Ventures V GP-GP (Canada) Inc. Versant Ventures V (Canada) L.P. Versant Venture Capital V (Canada) LP Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V L.P. 10% Owner | 2022-02-10 20:44:54 | 0 0 | 0 | Form 13G |